These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15385816)

  • 41. Transgenic animals in experimental xenotransplantation models: orthotopic heart transplantation in the pig-to-baboon model.
    Brandl U; Michel S; Erhardt M; Brenner P; Burdorf L; Jöckle H; Bittmann I; Rössle M; Mordstein V; Baschnegger H; Bauer A; Hammer C; Reichart B; Schmoeckel M
    Transplant Proc; 2007 Mar; 39(2):577-8. PubMed ID: 17362786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improvement in rejection of human decay accelerating factor transgenic pig-to-primate renal xenografts with administration of rabbit antithymocyte serum.
    Ghanekar A; Lajoie G; Luo Y; Yang H; Choi J; Garcia B; Cole EH; Greig PD; Cattral MS; Phillips MJ; Cardella CJ; Levy GA; Zhong R; Grant DR
    Transplantation; 2002 Jul; 74(1):28-35. PubMed ID: 12134095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide.
    Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G
    Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maintenance triple immunosuppression with cyclosporin A, mycophenolate sodium and steroids allows prolonged survival of primate recipients of hDAF porcine renal xenografts.
    Cozzi E; Vial C; Ostlie D; Farah B; Chavez G; Smith KG; Bradley JR; Thiru S; Davies HF; Wallwork J; White DJ; Goddard M; Friend PJ
    Xenotransplantation; 2003 Jul; 10(4):300-10. PubMed ID: 12795679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclophosphamide-induced postoperative anemia in cynomolgus monkey recipients of hDAF-transgenic pig organ xenografts.
    Lam TT; Hausen B; Squiers E; Cozzi E; Morris RE
    Transplant Proc; 2002 Aug; 34(5):1451-2. PubMed ID: 12176435
    [No Abstract]   [Full Text] [Related]  

  • 46. Co-stimulation blockade targeting CD154 and CD28/B7 modulates the induced antibody response after a pig-to-baboon cardiac xenograft.
    Wu G; Pfeiffer S; Schröder C; Zhang T; Nguyen BN; Lea W; Kelishadi S; Atkinson JB; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
    Xenotransplantation; 2005 May; 12(3):197-208. PubMed ID: 15807770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Xenotransplantation of galactosyl-transferase knockout, CD55, CD59, CD39, and fucosyl-transferase transgenic pig kidneys into baboons.
    Le Bas-Bernardet S; Tillou X; Poirier N; Dilek N; Chatelais M; Devallière J; Charreau B; Minault D; Hervouet J; Renaudin K; Crossan C; Scobie L; Cowan PJ; d'Apice AJ; Galli C; Cozzi E; Soulillou JP; Vanhove B; Blancho G
    Transplant Proc; 2011 Nov; 43(9):3426-30. PubMed ID: 22099813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human CD55 expression blocks hyperacute rejection and restricts complement activation in Gal knockout cardiac xenografts.
    McGregor CG; Ricci D; Miyagi N; Stalboerger PG; Du Z; Oehler EA; Tazelaar HD; Byrne GW
    Transplantation; 2012 Apr; 93(7):686-92. PubMed ID: 22391577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Xenotransplantation of solid organs in the pig-to-primate model.
    Ekser B; Rigotti P; Gridelli B; Cooper DK
    Transpl Immunol; 2009 Jun; 21(2):87-92. PubMed ID: 18955143
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contrast in the efficacy of hDAF mouse hearts between ex vivo perfusion and transplantation into primates.
    Verbakel CA; de Bruin RW; Bonthuis F; Jonker M; Dekker S; Marquet RL; IJzermans JN
    Xenotransplantation; 2001 Nov; 8(4):284-91. PubMed ID: 11737854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase).
    Ramírez P; Montoya MJ; Ríos A; García Palenciano C; Majado M; Chávez R; Muñoz A; Fernández OM; Sánchez A; Segura B; Sansano T; Acosta F; Robles R; Sánchez F; Fuente T; Cascales P; González F; Ruiz D; Martínez L; Pons JA; Rodríguez JI; Yélamos J; Cowan P; d'Apice A; Parrilla P
    Transplant Proc; 2005 Nov; 37(9):4103-6. PubMed ID: 16386637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HDAF transgenic pig livers are protected from hyperacute rejection during ex vivo perfusion with human blood.
    Luo Y; Levy G; Ding J; Qi J; Chakbrati S; Garcia BM; Phillips MJ; Kumar N; Friend P; Noble L; Macdonald J; Zhong R; Grant D
    Xenotransplantation; 2002 Jan; 9(1):36-44. PubMed ID: 12005103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
    Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
    Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival.
    Schirmer JM; Fass DN; Byrne GW; Tazelaar HD; Logan JS; McGregor CG
    Xenotransplantation; 2004 Sep; 11(5):436-43. PubMed ID: 15303980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The serum level of xenoantibodies, and hDAF or alphaGAL expression on pig cells, modulate in vitro the protection given by hDAF to primate complement-mediated damage.
    Díaz TM; Mañez R; Moscoso I; López D; Santamarina I; Lopez E; Centeno A; Domenéch N
    Transplant Proc; 2005; 37(1):510-1. PubMed ID: 15808692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors.
    Zaidi A; Schmoeckel M; Bhatti F; Waterworth P; Tolan M; Cozzi E; Chavez G; Langford G; Thiru S; Wallwork J; White D; Friend P
    Transplantation; 1998 Jun; 65(12):1584-90. PubMed ID: 9665074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ex vivo and extracorporeal perfusion with hDAF pig kidneys.
    Luo Y; Levy G; Garcia BM; Yang H; Phillips J; Noble L; Chakrabarti S; Grant D; Zhong R
    Xenotransplantation; 2003 Sep; 10(5):410-21. PubMed ID: 12950984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complement-mediated pulmonary xenograft injury: studies in swine-to-primate orthotopic single lung transplant models.
    Yeatman M; Daggett CW; Parker W; Byrne GW; Logan JS; Platt JL; Davis RD
    Transplantation; 1998 Apr; 65(8):1084-93. PubMed ID: 9583870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relation between human decay-accelerating factor (hDAF) expression in pig cells and inhibition of human serum anti-pig cytotoxicity: value of highly expressed hDAF for xenotransplantation.
    Liu D; Kobayashi T; Onishi A; Furusawa T; Iwamoto M; Suzuki S; Miwa Y; Nagasaka T; Maruyama S; Kadomatsu K; Uchida K; Nakao A
    Xenotransplantation; 2007 Jan; 14(1):67-73. PubMed ID: 17214706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitors.
    Mora M; Lazzer M; Marsicano G; Mulder LC; Carraresi L; Pieri A; Benanchi A; Grifoni D; Nuti S; Bruzzone P; Comporti M; Cortesini R; Rossini M
    Transgenic Res; 2000 Jun; 9(3):205-13. PubMed ID: 11032369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.